IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes

European Journal of Immunology

Volumn 38, Issue 3, 2008, Pages 788-796

  Koziczak Holbro, Magdalena ^a   Glück, Anton ^a   Tschopp, Claude ^a   Mathison, John C ^b   Gram, Hermann ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

IL 1R associated kinase 4; mRNA stability; Pro inflammatory signaling; Toll like receptor 4

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, MOUSE; CYTOKINE; I KAPPA B; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 6; IRAK4 PROTEIN, MOUSE; IRF3 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; RELA PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME REGULATION; GENE CONTROL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE; METABOLISM; MUTATION; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CHEMOKINE CCL2; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; INTERFERON REGULATORY FACTOR-3; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43649093749     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737886     Document Type: Article

References (45)

1. Kawai, T. and Akira, S., TLR signaling. Semin. Immunol. 2007. 19: 24-32.
2. Janssens, S. and Beyaert, R., Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 2003. 11: 293-302.
3. Martin, M. U. and Wesche, H., Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim. Biophys. Acta 2002. 1592: 265-280.
4. Kollewe, C., Mackensen, A. C., Neumann, D., Knop, J., Cao, P., Li, S., Wesche, H. and Martin, M. U., Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling. J. Biol. Chem. 2004. 279: 5227-5236.
5. Li, X. and Qin, J., Modulation of Toll-interleukin 1 receptor mediated signaling. J. Mol. Med. 2005. 83: 258-266.
6. Yamin, T. T. and Miller, D. K., The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 1997. 272: 21540-21547.
7. Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J. and Chen, Z. J., TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001. 412: 346-351.
8. Jiang, Z., Ninomiya-Tsuji, J., Qian, Y., Matsumoto, K. and Li, X., Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell Biol. 2002. 22: 7158-7167.
9. Tak, P. P. and Firestein, G. S., NF-kappaB: A key role in inflammatory diseases. J. Clin. Invest 2001. 107: 7-11.
10. Wisdom, R., AP-1: One switch for many signals. Exp. Cell Res. 1999. 253: 180-185.
11. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., Birdwell, D. et al., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998. 282: 2085-2088.
12. Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K. and Akira, S., Cutting edge: A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 2002. 169: 6668-6672.
13. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. and Akira, S., Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999. 11: 115-122.
14. Kawai, T., Takeuchi, O., Fujita, T., Inoue, J., Muhlradt, P. F., Sato, S., Hoshino, K. and Akira, S., Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001. 167: 5887-5894.
15. Doyle, S., Vaidya, S., O'Connell, R., Dadgostar, H., Dempsey, P., Wu, T., Rao, G. et al., IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002. 17: 251-263.
16. Suzuki, N., Suzuki, S. and Yeh, W. C., IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol. 2002. 23: 503-506.
17. Wietek, C. and O'Neill, L. A., IRAK-4: A new drug target in inflammation, sepsis, and autoimmunity. Mol. Interv. 2002. 2: 212-215.
18. Kuglstatter, A., Villasenor, A. G., Shaw, D., Lee, S. W., Tsing, S., Niu, L., Song, K.W. et al., Cutting edge: IL-1 receptor-associated kinase 4 structures reveal novel features and multiple conformations. J. Immunol. 2007. 178: 2641-2645.
19. Wang, Z., Liu, J., Sudom, A., Ayres, M., Li, S., Wesche, H., Powers, J. P. and Walker, N. P., Crystal structures of IRAK-4 kinase in complex with inhibitors: A serine/threonine kinase with tyrosine as a gatekeeper. Structure 2006. 14: 1835-1844.
20. Cheng, H., Addona, T., Keshishian, H., Dahlstrand, E., Lu, C., Dorsch, M., Li, Z. et al., Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop. Biochem. Biophys. Res. Commun. 2007. 352: 609-616.
21. Kawagoe, T., Sato, S., Jung, A., Yamamoto, M., Matsui, K., Kato, H., Uematsu, S. et al., Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J. Exp. Med. 2007. 204: 1013-1024.
22. Kim, T. W., Staschke, K., Bulek, K., Yao, J., Peters, K., Oh, K. H., Vandenburg, Y. et al., A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 2007. 204: 1025-1036.
23. Koziczak-Holbro, M., Joyce, C., Gluck, A., Kinzel, B., Muller, M., Tscoopp, C., Mathison, J. C. et al., IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression. J. Biol. Chem. 2007. 282: 13552-13560.
24. Lin, R., Heylbroeck, C., Pitha, P. M. and Hiscott, J., Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell Biol. 1998. 18: 2986-2996.
25. Menten, P., Proost, P., Struyf, S., Van Coillie, E., Put, W., Lenaerts, J. P., Conings, R. et al., Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity. Eur. J. Immunol. 1999. 29: 678-685.
26. Zhou, Z. H., Chaturvedi, P., Han, Y. L., Aras, S., Li, Y. S., Kolattukudy, P. E., Ping, D. et al., IFN-gamma induction of the human monocyte chemoattractant protein (hMCP)-1 gene in astrocytoma cells: Functional interaction between an IFN-gamma-activated site and a GC-rich element. J. Immunol. 1998. 160: 3908-3916.
27. Look, D. C., Pelletier,M. R. and Holtzman, M. J., Selective interaction of a subset of interferon-gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells. J. Biol. Chem. 1994. 269: 8952-8958.
28. Suzuki, N., Suzuki, S., Duncan, G. S., Millar, D. G., Wada, T., Mirtsos, C., Takada, H. et al., Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002. 416: 750-756.
29. Suzuki, N., Suzuki, S., Eriksson, U., Hara, H., Mirtosis, C., Chen, N. J., Wada, T. et al., IL-1R-associated kinase 4 is required for lipopolysaccharide-induced activation of APC. J. Immunol. 2003. 171: 6065-6071.
30. Takeda, K. and Akira, S., TLR signaling pathways. Semin. Immunol. 2004. 16: 3-9.
31. Covert, M. W., Leung, T. H., Gaston, J. E. and Baltimore, D., Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 2005. 309: 1854-1857.
32. Chen, C. Y. and Shyu, A. B., AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem. Sci. 1995. 20: 465-470.
33. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C. Y., Shyu, A. B., Muller, M. et al., The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 1999. 18: 4969-4980.
34. Ehlting, C., Lai, W. S., Schaper, F., Brenndorfer, E. D., Matthes, R. J., Heinrich, P. C., Ludwig, S. et al., Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade. J. Immunol. 2007. 178: 2813-2826.
35. Dean, J. L., Brook, M., Clark, A. R. and Saklatvala, J., p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 1999. 274: 264-269.
36. Brook, M., Sully, G., Clark, A. R. and Saklatvala, J., Regulation of tumour necrosis factor alpha mRNA stability by themitogen-activated protein kinase p38 signalling cascade. FEBS Lett. 2000. 483: 57-61.
37. Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H. D. and Gaestel, M., MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1999. 1: 94-97.
38. Frevel, M. A., Bakheet, T., Silva, A. M., Hissong, J. G., Khabar, K. S. and Williams, B. R., p38 Mitogen-activated protein kinase-dependent and-independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol. Cell Biol. 2003. 23: 425-436.
39. Tirumurugaan, K. G., Jude, J. A., Kang, B. N., Panettieri, R. A., Walseth, T. F. and Kannan, M. S., TNF-alpha induced CD38 expression in human airway smooth muscle cells: Role of MAP kinases and transcription factors NF-kappaB and AP-1. Am. J. Physiol Lung Cell Mol. Physiol 2007. 292: L1385-L1395.
40. Picard, C., Puel, A., Bonnet, M., Ku, C. L., Bustamante, J., Yang, K., Soudais, C. et al., Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003. 299: 2076-2079.
41. Medvedev, A. E., Lentschat, A., Kuhns, D. B., Blanco, J. C., Salkowski, C., Zhang, S., Arditi, M. et al., Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med. 2003. 198: 521-531.
42. Yang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C. L., Casrouge, A., Picard, C. et al., Human TLR-7-, -8-, and-9-mediated induction of IFN-alpha/beta and-lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005. 23: 465-478.
43. Theofilopoulos, A. N., Baccala, R., Beutler, B. and Kono, D. H., Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005. 23: 307-336.
44. Ku, C. L., von Bernuth, H., Picard, C., Zhang, S. Y., Chang, H. H., Yang, K., Chrabieh, M. et al., Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 2007. 204: 2407-2422.
45. Comalada, M., Xaus, J., Valledor, A. F., Lopez-Lopez, C., Pennington, D. J. and Celada, A., PKC epsilon is involved in JNK activation that mediates LPS-induced TNF-alpha, which induces apoptosis in macrophages. Am. J. Physiol. Cell Physiol. 2003. 285: C1235-C1245.